Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid disorders in diabetes.

R B Goldberg

    Diabetes Care
    |September 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Diabetic hyperlipidemia stems from complex metabolic factors. Management involves improving blood sugar control, diet, and sometimes medication to reduce risks of atherosclerosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

    The Journal of clinical endocrinology and metabolism·2015
    Same author

    Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2015
    Same author

    The disappearing high density lipoprotein syndrome.

    Journal of clinical lipidology·2015
    Same author

    Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.

    Diabetes, obesity & metabolism·2013
    Same author

    Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.

    Diabetic medicine : a journal of the British Diabetic Association·2012
    Same author

    Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program.

    Diabetic medicine : a journal of the British Diabetic Association·2012

    Area of Science:

    • Endocrinology
    • Metabolic Disorders
    • Lipid Metabolism

    Background:

    • Hyperlipidemia is prevalent in diabetic patients, yet its lipid and lipoprotein metabolism is not fully understood.
    • Diabetes mellitus is metabolically heterogeneous, influencing lipid profiles differently based on insulin deficiency, resistance, obesity, and genetics.

    Purpose of the Study:

    • To present a pathophysiologic approach to understanding hyperlipidemia in diabetes.
    • To discuss the roles of various factors in lipoprotein production and catabolism in diabetic individuals.

    Main Methods:

    • The study reviews existing knowledge on lipid metabolism in diabetes, focusing on lipoprotein lipase activity, very-low-density lipoprotein (VLDL) triglyceride production, and high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol levels.

    Related Experiment Videos

  • It examines the impact of insulin deficiency, insulin resistance, obesity, and genetic factors on these parameters.
  • Therapeutic strategies including glycemic control, dietary modifications, and pharmacotherapy are discussed.

    • Main Results:

    • Insulin deficiency is linked to lipoprotein lipase deficiency, impairing triglyceride-rich lipoprotein removal.
    • Non-insulin-dependent diabetes may involve lipoprotein removal defects and VLDL-triglyceride overproduction.
    • HDL-cholesterol may increase in insulin-dependent diabetes but decrease in obese non-insulin-dependent patients; LDL-cholesterol can elevate in poorly controlled diabetes.

    Conclusions:

    • Diabetic hyperlipidemia results from an interplay between the diabetic state, genetic predisposition, and environmental factors.
    • Effective management requires addressing glycemic control, diet, weight, and potentially medication.
    • Understanding the specific metabolic derangements is crucial for tailored therapeutic interventions.